| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |